PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1618170
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1618170
Amniotic Membrane Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
The Global Amniotic Membrane Market was valued at USD 1.7 billion in 2023 and is projected to experience a CAGR of 7.9% from 2024 to 2032. The amniotic membrane is a delicate, flexible tissue that lines the amniotic sac during pregnancy, serving as a protective barrier for the developing fetus while supplying vital nutrients and growth factors. Following childbirth, this membrane finds utility in various medical treatments and surgeries due to its regenerative properties that promote healing. The increasing focus on regenerative medicine is expected to be a significant growth driver. This field aims to restore or replace damaged tissues and organs through innovative methods such as stem cell therapy, tissue engineering, and biomaterials.
Amniotic membranes are gaining recognition for their potential in these applications, primarily because of their distinctive properties. Recent studies have highlighted the presence of key bioactive molecules within the amniotic membrane, reinforcing its role in regenerative medicine. In terms of product types, the market can be categorized into cryopreserved and lyophilized amniotic membranes. The cryopreserved segment is anticipated to reach USD 1.7 billion by 2032, primarily due to its extensive application across multiple medical disciplines.
In ophthalmology, cryopreserved amniotic membranes are used to treat various corneal defects, including persistent epithelial defects, ulcers, and chemical burns. This application aids in accelerating healing while minimizing inflammation and scarring. The ophthalmology segment led the market in 2023, with revenues reaching USD 342.1 million. Amniotic membrane transplantation (AMT) is utilized in this field to manage several ocular surface disorders.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $1.7 Billion |
| Forecast Value | $3.2 Billion |
| CAGR | 7.9% |
The amniotic membrane, being the innermost layer of the placenta, provides various benefits, such as supporting epithelial cell growth through its collagen composition, reducing inflammation, preventing angiogenesis, and offering analgesic effects by covering sensitive nerve endings. In the United States, the amniotic membrane market is projected to reach USD 1.1 billion by 2032. This growth can be attributed to advanced healthcare facilities and key industry players. The rising emphasis on regenerative medicine, in line with rapid technological advancements, is expected to fuel further market expansion.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market segmentation
- 1.2 Market definition
- 1.3 Research design
- 1.4 Market size estimates and calculations
- 1.5 Key trends for market estimates
- 1.6 Forecast model
- 1.7 Primary research & validation
- 1.7.1 Primary sources
- 1.7.2 Data mining sources
- 1.7.2.1 Paid sources
- 1.7.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis, 2018 - 2032
- 2.2 Product trends
- 2.3 Application trends
- 2.4 End-use trends
- 2.5 Regional trends
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing demand for regenerative medicine
- 3.2.1.2 Rising incidence of chronic wounds
- 3.2.1.3 Advancements in biotechnology and tissue engineering
- 3.2.1.4 Increasing awareness and acceptance of amniotic membrane products
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Limited shelf life of amniotic membrane products
- 3.2.2.2 Stringent regulatory polices
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By application
- 3.3.3 By end-use
- 3.4 Regulatory landscape
- 3.5 Reimbursement scenario
- 3.6 Technology landscape
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Cryopreserved
- 5.3 Lyophilized
Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Surgical wounds
- 6.3 Ophthalmology
- 6.4 Stem cell biology
- 6.5 Regenerative medicine
- 6.6 Prenatal diagnosis
- 6.7 Orthopedics
- 6.8 Dermatology
- 6.9 Plastic surgery
- 6.10 Dentistry
- 6.11 Gynecology
Chapter 7 Market Estimates and Forecast, By End Use, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Ambulatory surgical centers (ASCs)
- 7.4 Specialty clinics
- 7.5 Research and academic institutes
- 7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Amnio Technology, LLC
- 9.2 Applied Biologics LLC
- 9.3 BioTissue Holdings Inc.
- 9.4 Celularity Inc.
- 9.5 Corza Health, Inc.
- 9.6 Integra LifeSciences Holdings Corporation
- 9.7 MiMedx Group, Inc.
- 9.8 Organogenesis Holdings Inc.
- 9.9 Skye Biologics, Inc.
- 9.10 Smith & Nephew plc
